0120 ECP Aulos
BioCentury & Getty Images

Emerging Company Profile

Aulos: Tackling the IL-2 space with computational biology

Emerging Company Profile: Aulos believes its computationally designed mAb will stand out in IL-2

Apple Tree-backed Aulos believe its computationally designed mAb will stand out in the IL-2 crowd.

Jan 20, 2021 | 8:11 PM GMT

Apple Tree Partners launched Aulos into the crowded IL-2 space last week with a $40 million series A round and a computationally designed IL-2-binding antibody it thinks could

Read the full 773 word article

How to gain access

Continue reading with a
two-week free trial.